-
Adler S P, Marshall B. 2007. Cytomegalovirus in-fections. Pediatr Rev, 28: 92-100.
doi: 10.1542/pir.28-3-92
-
Ahn K, Angulo A, Ghazal P, et al. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA, 93: 10990-10995.
doi: 10.1073/pnas.93.20.10990
-
Ahn K, Gruhler A, Galocha B, et al. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity, 6: 613-621.
doi: 10.1016/S1074-7613(00)80349-0
-
Arase H, Mocarski E S, Campbell A E, et al. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science, 296: 1323-1326.
doi: 10.1126/science.1070884
-
Askin D F. 2004. Intrauterine infections. Neonatal Netw, 23: 23-30.
doi: 10.1891/0730-0832.23.5.23
-
Atreya I, Atreya R, Neurath M F. 2008. NF-kappaB in inflammatory bowel disease. J Intern Med, 263:591-596.
doi: 10.1111/j.1365-2796.2008.01953.x
-
Bale J F. 2002. Congenital infections. Neurol Clin, 20:1039-1060.
doi: 10.1016/S0733-8619(02)00014-2
-
Bason C, Corrocher R, Lunardi C, et al. 2003. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet, 362: 1971-1977.
doi: 10.1016/S0140-6736(03)15016-7
-
Basta S, Bennink J R. 2003. A survival game of hide and seek: cytomegaloviruses and MHC class Ⅰ antigen presentation pathways. Viral Immunol, 16: 231-242.
doi: 10.1089/088282403322396064
-
Bauer D, Tampe R. 2002. Herpes viral proteins blocking the transporter associated with antigen processing TAP--from genes to function and structure. Curr Top Micro-biol Immunol, 269: 87-99.
-
Bego M G, St Jeor S. 2006. Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency. Exp Hematol, 34: 555-570.
doi: 10.1016/j.exphem.2005.11.012
-
Beisser P S, Goh C S, Cohen F E, et al. 2002. Viral chemokine receptors and chemokines in human cytomega-lovirus trafficking and interaction with the immune system. CMV chemokine receptors. Curr Top Microbiol Im-munol, 269: 203-34.
-
Bentz G L, Yurochko A D. 2008. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci USA, 105: 5531-5536.
doi: 10.1073/pnas.0800037105
-
Boomker J M, de Jong E K, de Leij L F, et al. 2006. Chemokine scavenging by the human cytomegalovirus chemokine decoy receptor US28 does not inhibit monocyte adherence to activated endothelium. Antiviral Res, 69: 124-127.
doi: 10.1016/j.antiviral.2005.11.003
-
Boomker J M, van Luyn M J, The T H, et al. 2005. US28 actions in HCMV infection: lessons from a versa-tile hijacker. Rev Med Virol, 15: 269-282.
doi: 10.1002/(ISSN)1099-1654
-
Braud V M, Tomasec P, Wilkinson G W. 2002. Viral evasion of natural killer cells during human cytomega-lovirus infection. Curr Top Microbiol Immunol, 269: 117-129.
-
Bryant P, Morley C, Garland S, et al. 2002. Cytomega-lovirus transmission from breast milk in premature babies: does it matter? Arch Dis Child Fetal Neonatal Ed, 87: F75-77.
doi: 10.1136/fn.87.2.F75
-
Candore G, Balistreri C R, Colonna-Romano G, et al. 2008. Immunosenescence and anti-immunosenescence therapies: the case of probiotics. Rejuvenation Res, 11: 425-432.
doi: 10.1089/rej.2008.0662
-
Chalupny N J, Rein-Weston A, Dosch S, et al. 2006. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun, 346: 175-181.
doi: 10.1016/j.bbrc.2006.05.092
-
Chang M, Pan M R, Chen D Y, et al. 2006. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice. Clin Exp Immunol, 143: 167-179.
doi: 10.1111/cei.2006.143.issue-1
-
Chapman T L, Heikeman A P, Bjorkman P J. 1999. The inhibitory receptor LIR-1 uses a common binding interac-tion to recognize class Ⅰ MHC molecules and the viral homolog UL18. Immunity, 11: 603-613.
doi: 10.1016/S1074-7613(00)80135-1
-
Cosman D, Mullberg J, Sutherland C L, et al. 2001. ULBPs, novel MHC class Ⅰ-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 14: 123-133.
doi: 10.1016/S1074-7613(01)00095-4
-
Criscuoli V, Rizzuto M R, Cottone M. 2006. Cytomega-lovirus and inflammatory bowel disease: is there a link? World J Gastroenterol, 12: 4813-4818.
-
Damato E G, Winnen C W. 2002. Cytomegalovirus infection: perinatal implications. J Obstet Gynecol Neo-natal Nurs, 31: 86-92.
doi: 10.1111/j.1552-6909.2002.tb00026.x
-
Davison A J, Dolan A, Akter P, et al. 2003. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol, 84: 17-28.
doi: 10.1099/vir.0.18606-0
-
DeFilippis V R. 2007. Induction and evasion of the type Ⅰ interferon response by cytomegaloviruses. Adv Exp Med Biol, 598:309-24.
doi: 10.1007/978-0-387-71767-8
-
Diaz F, Urkijo J C, Mendoza F, et al. 2006. Systemic lupus erythematosus associated with acute cytomega-lovirus infection. J Clin Rheumatol, 12: 263-264.
doi: 10.1097/01.rhu.0000239832.74804.17
-
Dimitroulia E, Spanakis N, Konstantinidou A E, et al. 2006. Frequent detection of cytomegalovirus in the in-testine of patients with inflammatory bowel disease. Inflamm Bowel Dis, 12: 879-884.
doi: 10.1097/01.mib.0000231576.11678.57
-
Dugan G E, Hewitt E W. 2008. Structural and Func-tional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6. J Virol, 82: 3271-3282.
doi: 10.1128/JVI.01705-07
-
Dunn C, Chalupny N J, Sutherland C L, et al. 2003. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med, 197: 1427-1439.
doi: 10.1084/jem.20022059
-
Dunn W, Chou C, Li H, et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA, 100: 14223-14228.
doi: 10.1073/pnas.2334032100
-
Editorial Comments. 2004. Cytomegalovirus. Am J Transplant, 4 Suppl 10:51-58.
-
Emery V C. 2001. Cytomegalovirus and the aging popu-lation. Drugs Aging, 18: 927-933.
doi: 10.2165/00002512-200118120-00004
-
Emery V C. 2001. Investigation of CMV disease in immunocompromised patients. J Clin Pathol, 54: 84-88.
doi: 10.1136/jcp.54.2.84
-
Franceschi C. 2007. Inflammaging as a major charac-teristic of old people: can it be prevented or cured? Nutr Rev, 65: S173-176.
-
Franceschi C, Bonafe M. 2003. Centenarians as a model for healthy aging. Biochem Soc Trans 31: 457-61.
doi: 10.1042/bst0310457
-
Froberg M K. 2004. Review: CMV escapes! Ann Clin Lab Sci, 34: 123-130.
-
Gewurz B E, Gaudet R, Tortorella D, et al. 2001. Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class Ⅰ mo-lecule HLA-A2. Proc Natl Acad Sci USA, 98: 6794-6799.
doi: 10.1073/pnas.121172898
-
Giunta S. 2006. Is inflammaging an auto[innate] immunity subclinical syndrome? Immun Ageing, 3: 12.
doi: 10.1186/1742-4933-3-12
-
Gold E, Nankervis G A. 1976. Cytomegalovirus. In: Viral infections of humans: epidemiology and control (Evans A S ed.), Plenum Press: New York, p 143-161.
-
Goldmacher V S. 2005. Cell death suppression by cytomegaloviruses. Apoptosis, 10: 251-265.
doi: 10.1007/s10495-005-0800-z
-
Goldmacher V S. 2002. vMIA, a viral inhibitor of apo-ptosis targeting mitochondria. Biochimie, 84: 177-185.
doi: 10.1016/S0300-9084(02)01367-6
-
Hengel H, Koopmann J O, Flohr T, et al. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.Immunity, 6: 623-632.
doi: 10.1016/S1074-7613(00)80350-7
-
Hommes D W, Sterringa G, van Deventer S J, et al. 2004. The pathogenicity of cytomegalovirus in inflam-matory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis, 10: 245-250.
doi: 10.1097/00054725-200405000-00011
-
Hooper M, Kallas E G, Coffin D, et al. 1999. Cytomega-lovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol, 26: 1452-1457.
-
Hrycek A, Kusmierz D, Mazurek U, et al. 2005. Human cytomegalovirus in patients with systemic lupus ery-thematosus. Autoimmunity, 38: 487-491.
doi: 10.1080/08916930500285667
-
Hussein K, Hayek T, Yassin K, et al. 2006. Acute cytomegalovirus infection associated with the onset of inflammatory bowel disease. Am J Med Sci, 331: 40-43.
doi: 10.1097/00000441-200601000-00012
-
Jarvis M A, Borton J A, Keech A M, et al. 2006. Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation. J Virol, 80: 5588-5598.
doi: 10.1128/JVI.00060-06
-
Jarvis M A, Nelson J A. 2002. Human cytomegalovirus persistence and latency in endothelial cells and macrop-hages.Curr Opin Microbiol, 5:403-407.
doi: 10.1016/S1369-5274(02)00334-X
-
Jarvis M A, Nelson J A. 2002. Mechanisms of human cytomegalovirus persistence and latency. Front Biosci, 7:d1575-1582.
doi: 10.2741/A862
-
Jenkins C, Abendroth A, Slobedman B. 2004. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol, 78: 1440-1447.
doi: 10.1128/JVI.78.3.1440-1447.2004
-
Johnson D C, Hegde N R. 2002. Inhibition of the MHC class Ⅱ antigen presentation pathway by human cytomega-lovirus. Curr Top Microbiol Immunol, 269: 101-115.
-
Jones T R, Wiertz E J, Sun L, et al. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class Ⅰ heavy chains. Proc Natl Acad Sci USA, 93: 11327-11333.
doi: 10.1073/pnas.93.21.11327
-
Jurak I, Brune W. 2006. Induction of apoptosis limits cytomegalovirus cross-species infection. Embo J, 25: 2634-2642.
doi: 10.1038/sj.emboj.7601133
-
Kanapeckiene V, Kalibatas J, Redaitiene E, et al. 2007. The association between cytomegalovirus infection and aging process. Medicina (Kaunas), 43: 419-424.
-
Kavanagh D G, Hill A B. 2001. Evasion of cytotoxic T lymphocytes by murine cytomegalovirus. Semin Im-munol, 13: 19-26.
doi: 10.1006/smim.2001.0292
-
Kerrey B T, Morrow A, Geraghty S, et al. 2006. Breast milk as a source for acquisition of cytomegalovirus (HCMV) in a premature infant with sepsis syndrome: detection by real-time PCR. J Clin Virol, 35: 313-316.
doi: 10.1016/j.jcv.2005.09.013
-
Khan N. 2007. The immunological burden of human cytomegalovirus infection. Arch Immunol Ther Exp (Warsz), 55: 299-308.
doi: 10.1007/s00005-007-0037-3
-
Khan N, Hislop A, Gudgeon N, et al. 2004. Herpes-virus-specific CD8 T cell immunity in old age: cytomega-lovirus impairs the response to a coresident EBV infection. J Immunol, 173: 7481-7489.
doi: 10.4049/jimmunol.173.12.7481
-
Khan N, Shariff N, Cobbold M, et al. 2002. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol, 169: 1984-1992.
doi: 10.4049/jimmunol.169.4.1984
-
Khoshnevis M, Tyring S K. 2002. Cytomegalovirus infections. Dermatol Clin, 20:291-299, vii.
doi: 10.1016/S0733-8635(01)00007-9
-
Kinney J S, Onorato I M, Stewart J A, et al. 1985. Cytomegaloviral infection and disease. J Infect Dis, 151: 772-774.
doi: 10.1093/infdis/151.5.772
-
Kojima T, Watanabe T, Hata K, et al. 2006. Cytomega-lovirus infection in ulcerative colitis. Scand J Gastroen-terol, 41: 706-711.
doi: 10.1080/00365520500408584
-
Koutouzov S, Jeronimo A L, Campos H, et al. 2004. Nucleosomes in the pathogenesis of systemic lupus ery-thematosus.Rheum Dis Clin North Am, 30: 529-558, ix.
doi: 10.1016/j.rdc.2004.04.001
-
Krmpotic A, Bubic I, Polic B, et al. 2003. Pathogenesis of murine cytomegalovirus infection. Microbes Infect, 5: 1263-1277.
doi: 10.1016/j.micinf.2003.09.007
-
Landolfo S, Gariglio M, Gribaudo G, et al. 2003. The human cytomegalovirus. Pharmacol Ther, 98: 269-297.
doi: 10.1016/S0163-7258(03)00034-2
-
Lehner P J, Karttunen J T, Wilkinson G W, et al. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci USA, 94: 6904-6909.
doi: 10.1073/pnas.94.13.6904
-
Lenac T, Arapovic J, Traven L, et al. 2008. Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol, 197: 159-166.
doi: 10.1007/s00430-008-0080-7
-
Lin A, Xu H, Yan W. 2007. Modulation of HLA expres-sion in human cytomegalovirus immune evasion. Cell Mol Immunol, 4: 91-98.
-
Lodoen M B, Abenes G, Umamoto S, et al. 2004. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med, 200: 1075-1081.
doi: 10.1084/jem.20040583
-
Loenen W A, Bruggeman C A, Wiertz E J. 2001. Im-mune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol, 13: 41-49.
doi: 10.1006/smim.2001.0294
-
Lunardi C, Bason C, Corrocher R, et al. 2005. Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol, 26: 19-24.
doi: 10.1016/j.it.2004.10.009
-
Lunardi C, Bason C, Navone R, et al. 2000. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med, 6: 1183-1186.
doi: 10.1038/80533
-
Lunardi C, Dolcino M, Peterlana D, et al. 2006. Antibodies against human cytomegalovirus in the patho-genesis of systemic sclerosis: a gene array approach. PLoS Med, 3: e2.
-
Lunardi C, Dolcino M, Peterlana D, et al. 2007. Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS ONE, 2: e473
doi: 10.1371/journal.pone.0000473
-
Mattey D L, Dawes P T, Nixon N B, et al. 2004. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Ann Rheum Dis, 63: 420-425.
doi: 10.1136/ard.2003.008011
-
McCormick A L. 2008. Control of apoptosis by human cytomegalovirus. Curr Top Microbiol Immunol, 325: 281-295.
-
Mehraein Y, Lennerz C, Ehlhardt S, et al. 2004. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA-and DNA-in situ hybridization. Mod Pathol, 17: 781-789.
doi: 10.1038/modpathol.3800119
-
Mocarski E S. 2002. Immunomodulation by cytomega-loviruses: manipulative strategies beyond evasion. Trends Microbiol, 10:332-339.
doi: 10.1016/S0966-842X(02)02393-4
-
Mocarski E S. Courcelle, C. T. Cytomegalovirus and their replication, In: Fields' Virology (Knipe D M, Howley P M, ed. ), Lippincott : Philadelphia, p2629-2673.
-
Murphy E, Rigoutsos I, Shibuya T, et al. 2003. Reevaluation of human cytomegalovirus coding potential. Proc Natl Acad Sci USA, 100: 13585-13590.
doi: 10.1073/pnas.1735466100
-
Murphy E, Yu D, Grimwood J, et al. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA, 100: 14976-14981.
doi: 10.1073/pnas.2136652100
-
Namboodiri A M, Rocca K M, Kuwana M, et al. 2006. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Clin Exp Rheumatol, 24: 176-178.
-
Noyola D E, Valdez-Lopez B H, Hernandez-Salinas A E, et al. 2005. Cytomegalovirus excretion in children attending day-care centers. Arch Med Res, 36: 590-593.
doi: 10.1016/j.arcmed.2005.03.045
-
Pandey J P. 2004. Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Clin Exp Rheumatol, 22: S35-7.
-
Pass R F. 2001. Cytomegalovirus, In: Fields' Virology (Knipe D M, Howley P M ed. ), Lippincott: Philadelphia, p2675-2705.
-
Pass R F. 2002. Cytomegalovirus infection. Pediatr Rev, 23: 163-170.
doi: 10.1542/pir.23-5-163
-
Pass R F. 1985. Epidemiology and transmission of cytomegalovirus. J Infect Dis, 152: 243-248.
doi: 10.1093/infdis/152.2.243
-
Pawelec G, Gouttefangeas C. 2006. T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence? Aging Clin Exp Res, 18: 171-173.
doi: 10.1007/BF03327436
-
Pawelec G, Larbi A. 2008. Immunity and ageing in man: Annual Review 2006/2007. Exp Gerontol, 43: 34-38.
-
Peichl P, Scriba M, Haberhauer G, et al. 1988. Selective binding of rheumatoid factors to antigen structures of cytomegalovirus (CMV). Scand J Rheumatol, Suppl 75: 117-122.
-
Pereira L, Maidji E, McDonagh S, et al. 2005. Insights into viral transmission at the uterine-placental interface. Trends Microbiol, 13: 164-174.
doi: 10.1016/j.tim.2005.02.009
-
Plachter B, Sinzger C, Jahn G. 1996. Cell types in-volved in replication and distribution of human cytomega-lovirus. Adv Virus Res, 46: 195-261.
doi: 10.1016/S0065-3527(08)60073-1
-
Rafailidis P I, Mourtzoukou E G, Varbobitis I C, et al. 2008. Severe cytomegalovirus infection in apparently im-munocompetent patients: a systematic review. Virol J, 5: 47.
doi: 10.1186/1743-422X-5-47
-
Rahbar A, Bostrom L, Soderberg-Naucler C. 2006. Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease. J Autoimmun, 26: 155-164.
doi: 10.1016/j.jaut.2006.02.003
-
Rajagopalan S, Long E O. 2005. Viral evasion of NK-cell activation. Trends Immunol, 26: 403-405.
doi: 10.1016/j.it.2005.06.008
-
Randolph-Habecker J R, Rahill B, Torok-Storb B, et al. 2002. The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine, 19: 37-46.
doi: 10.1006/cyto.2002.0874
-
Rawlinson W D, Farrell H E, Barrell B G. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol, 70: 8833-8849.
-
Reddehase M J, Podlech J, Grzimek N K. 2002. Mouse models of cytomegalovirus latency: overview. J Clin Virol, 25 Suppl 2:S23-36.
-
Reeves M B, Lehner P J, Sissons J G, et al. 2005. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol, 86: 2949-2954.
doi: 10.1099/vir.0.81161-0
-
Reeves M B, MacAry P A, Lehner P J, et al. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA, 102: 4140-4145.
doi: 10.1073/pnas.0408994102
-
Reynolds D W, Stagno S, Alford C A. 1981. Chronic congenital and perinatal infections, In: Neonatal pathop-hysiolaogy and management in the newborn (Avery G B, ed. ). Lippincott : Philadelphia, p748-789.
-
Rezania D, Ouban A, Marcet J, et al. 2007. CMV colitis mimicking recurrent inflammatory bowel disease: report of three cases. Am Surg, 73: 58-61.
-
Roback J D. 2002. CMV and blood transfusions. Rev Med Virol, 12: 211-219.
doi: 10.1002/(ISSN)1099-1654
-
Robinson J. 2001. Infectious diseases in schools and child care facilities. Pediatr Rev, 22: 39-46.
doi: 10.1542/pir.22-2-39
-
Ross S A, Boppana S B. 2005. Congenital cytomega-lovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis, 16: 44-49.
doi: 10.1053/j.spid.2004.09.011
-
Sansoni P, Vescovini R, Fagnoni F, et al. 2008. The immune system in extreme longevity. Exp Gerontol, 43: 61-65.
doi: 10.1016/j.exger.2007.06.008
-
Scalzo A A, Corbett A J, Rawlinson W D, et al. 2007. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol, 85: 46-54.
doi: 10.1038/sj.icb.7100013
-
Schleiss M R. 2003. Vertically transmitted herpesvirus infections. Herpes, 10:4-11.
-
Sekigawa I, Nawata M, Seta N, et al. 2002. Cytomega-lovirus infection in patients with systemic lupus ery-thematosus.Clin Exp Rheumatol, 20: 559-564.
-
Sinclair J. 2008. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J Clin Virol, 41: 180-185.
doi: 10.1016/j.jcv.2007.11.014
-
Sinclair J, Sissons P. 2006. Latency and reactivation of human cytomegalovirus. J Gen Virol, 87: 1763-1779.
doi: 10.1099/vir.0.81891-0
-
Sinzger C, Jahn G. 1996. Human cytomegalovirus cell tropism and pathogenesis. Intervirology, 39: 302-319.
doi: 10.1159/000150502
-
Sissons J G, Bain M, Wills M R. 2002. Latency and reactivation of human cytomegalovirus. J Infect, 44: 73-77.
doi: 10.1053/jinf.2001.0948
-
Skaletskaya A, Bartle L M, Chittenden T, et al. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci USA, 98: 7829-7834.
doi: 10.1073/pnas.141108798
-
Smith H R, Heusel J W, Mehta I K, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA, 99: 8826-8831.
doi: 10.1073/pnas.092258599
-
Smith M G. 1956. Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med, 92: 424-440.
doi: 10.3181/00379727-92-22498
-
Smith M G. 1954. Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med, 86: 435-440.
doi: 10.3181/00379727-86-21123
-
Soderberg-Naucler C, Fish K N, Nelson J A. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell, 91: 119-126.
doi: 10.1016/S0092-8674(01)80014-3
-
Soderberg-Naucler C, Streblow D N, Fish K N, et al. 2001. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol, 75: 7543-7554.
doi: 10.1128/JVI.75.16.7543-7554.2001
-
Stahl H D, Hubner B, Seidl B, et al. 2000. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis, 59: 342-346.
doi: 10.1136/ard.59.5.342
-
Staras S A, Dollard S C, Radford K W, et al. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis, 43: 1143-1151.
doi: 10.1086/508173
-
Streblow D N, Dumortier J, Moses A V, et al. 2008. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol, 325: 397-415.
-
Sutherland C L, Chalupny N J, Schooley K, et al. 2002. UL16-binding proteins, novel MHC class Ⅰ-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol, 168: 671-679.
doi: 10.4049/jimmunol.168.2.671
-
Tang Q, Maul G G. 2006. Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins. J Virol, 80: 7510-7521.
doi: 10.1128/JVI.00684-06
-
Terhune S, Torigoi E, Moorman N, et al. 2007. Human cytomegalovirus UL38 protein blocks apoptosis. J Virol, 81: 3109-3123.
doi: 10.1128/JVI.02124-06
-
Thompson J N. 1994. The Coevolutionary Process. University of Chicago Press: Chicago, USA.
-
Tsuchiya N, Murayama T, Yoshinoya S, et al. 1993. Antibodies to human cytomegalovirus 65-kilodalton Fc binding protein in rheumatoid arthritis: idiotypic mimicry hypothesis of rheumatoid factor production. Autoim-munity, 15: 39-48.
doi: 10.3109/08916939309004837
-
Vancikova Z, Dvorak P. 2001. Cytomegalovirus in-fection in immunocompetent and immunocompromised individuals--a review. Curr Drug Targets Immune Endocr Metabol Disord, 1: 179-187.
doi: 10.2174/1568005310101020179
-
Vasto S, Colonna-Romano G, Larbi A et al. 2007. Role of persistent CMV infection in configuring T cell immunity in the elderly.Immun Ageing, 4: 2.
doi: 10.1186/1742-4933-4-2
-
Verdonk R C, Haagsma E B, Van Den Berg A P, et al. 2006. Inflammatory bowel disease after liver trans-plantation: a role for cytomegalovirus infection. Scand J Gastroenterol, 41: 205-211.
doi: 10.1080/00365520500206293
-
Vescovini R, Biasini C, Fagnoni F F, et al. 2007. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol, 179: 4283-4291.
doi: 10.4049/jimmunol.179.6.4283
-
Vink C, Beuken E, Bruggeman C A. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J Virol, 74: 7656-7665.
doi: 10.1128/JVI.74.16.7656-7665.2000
-
Vitale M, Castriconi R, Parolini S, et al. 1999. The leukocyte Ig-like receptor (LIR)-1 for the cytomega-lovirus UL18 protein displays a broad specificity for different HLA class Ⅰ alleles: analysis of LIR-1 + NK cell clones. Int Immunol, 11: 29-35.
doi: 10.1093/intimm/11.1.29
-
Voigt S, Mesci A, Ettinger J, et al. 2007. Cytomega-lovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity, 26: 617-627.
doi: 10.1016/j.immuni.2007.03.013
-
Wagner C S, Ljunggren H G, Achour A. 2008. Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J Immunol, 180: 19-24.
doi: 10.4049/jimmunol.180.1.19
-
Waller E C, Day E, Sissons J G, et al. 2008. Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol, 197: 83-96.
doi: 10.1007/s00430-008-0082-5
-
Weller T H, Hanshaw J B, Scott D E. 1960. Serological differentiation of viruses responsible for cytomegalic inclusion disease. Virology, 12: 130-132.
doi: 10.1016/0042-6822(60)90156-2
-
Wiertz E J, Jones T R, Sun L, et al. 1996. The human cytomegalovirus US11 gene product dislocates MHC class Ⅰ heavy chains from the endoplasmic reticulum to the cytosol. Cell, 84: 769-779.
doi: 10.1016/S0092-8674(00)81054-5
-
Woolhouse M E, Webster J P, Domingo E, et al. 2002. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet, 32: 569-577.
doi: 10.1038/ng1202-569
-
Yi L, Lin J Y, Gao Y, et al. 2008. Detection of human cytomegalovirus in the atherosclerotic cerebral arteries in han population in china. Acta Virol, 52: 99-106.
-
Ziemann M, Krueger S, Maier A B, et al. 2007. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Transfusion, 47: 1972-1983.
doi: 10.1111/trf.2007.47.issue-11